Untreated atrial fibrillation carries an approximately 3 to 5% annual risk of ischemic stroke. Long-term oral anticoagulation therapy decreases this risk to 1.7% with warfarin and to 1.5% with ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation and high risk for stroke and bleeding, left atrial appendage occlusion was ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...

On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...

WASHINGTON, DC—Single antiplatelet therapy may be a reasonable antithrombotic choice for some patients with atrial fibrillation who undergo left atrial appendage (LAA) occlusion, according to ...

Validation of the HFA-ICOS cardiovascular toxicity risk tool in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors: Real-world data from the Saudi population. This is an ASCO ...

SAN FRANCISCO, CA—Direct oral anticoagulants (DOACs) don’t reduce device-related thrombosis (DRT) compared with dual antiplatelet therapy (DAPT) following left atrial appendage occlusion (LAAO), but ...

In the PROTECT AF trial, patients randomized to left atrial appendage closure initially continued taking warfarin and aspirin to promote device endothelialization. At 45 days after the procedure, 86.8 ...